BLACKMAN RONALD K has a total of 13 patent applications. Its first patent ever was published in 2001. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are AI THERAPEUTICS INC, QU BIOLOGICS INC and CISTRON BIOTECHNOLOGY INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 10 | |
#2 | WIPO (World Intellectual Property Organization) | 3 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Analysing materials | |
#4 | Measuring microorganism processes | |
#5 | Peptides | |
#6 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Blackman Ronald K | 13 |
#2 | Proia David | 6 |
#3 | Vukovic Vojo | 5 |
#4 | Foley Kevin Paul | 4 |
#5 | Foley Kevin P | 2 |
#6 | Bulawa Christine | 1 |
#7 | Gutierrez Juan Antonio | 1 |
#8 | Bulawa Christine Ellen | 1 |
#9 | Gavrias Victoria | 1 |
#10 | Keaveney Marie | 1 |
Publication | Filing date | Title |
---|---|---|
US2014045908A1 | Hsp90 inhibitory compounds in treating jak/stat signaling-mediated cancers | |
US2012128580A1 | Preselection of subjects for therapeutic treatment with elesclomol based on hypoxic status | |
US2013156755A1 | Cancer therapy using a combination of a hsp90 inhibitory compounds and a vegf inhibitor |